Monthly Archives: February 2011

Creosalus Delivers First Sucromate™ Equine Product

In Time for Upcoming Mare Breeding Season
First of its Kind Drug Developed and Manufactured in Kentucky

CreoSalus, Inc. announced its subsidiary Thorn BioScience shipped its first SucroMate ™ Equine vials for the upcoming mare breeding season. SucroMate™ Equine regulates ovulation in mares of all breeds through a single injection allowing for timed ovulation and breeding for both naturally bred and artificially inseminated mares.

Co-Founder Barry Simon, DVM said, “We are pleased to introduce FDA approved SucroMate™ Equine for the 2011 breeding season. Owners and veterinarians can breed their mares confidently knowing that SucroMate™ Equine is delivering a stable, sterile, and consistent dose. Horsemen will no longer need to rely on compounded products that may not meet safety or efficacy specifications. SucroMate™ Equine is another step in improving the health of the Thoroughbred and other equine based industries.”

SucroMate™ Equine is distributed in the United States through partnership with Bioniche Life Sciences (TSX : BNC). Bioniche’s Animal Health division specializes in animal reproduction including embryo transfer, immunostimulants, and nutrition. SucroMate™ Equine is now available for veterinarians through distributors.

Thorn BioScience received FDA approval of SucroMate™ Equine in November 2010. SucroMate™ Equine is the first FDA approved drug of its kind developed and manufactured in Kentucky.

SucroMate™ Equine is manufactured in CreoSalus’ Class 5 aseptic clean room under the FDA’s current Good Manufacturing Process (cGMP). This Class 5 clean room is the only one in Kentucky for commercial manufacturing of pharmaceuticals. SucroMate™ Equine utilizes DURECT Corporation’s (NASQ: DRRX) Saber™ technology.

About CreoSalus

CreoSalus is a privately held Louisville, Kentucky based life-sciences company with businesses specializing in the development and manufacturing of finished drugs (Thorn BioScience), human medical devices (Occam Design), and fine chemicals (Advanced ChemTech). Thorn BioScience’s products include SucroMate™ Porcine (under development) and FDA approved SucroMate™ Equine that regulate ovulation in sows and mares, respectively. CreoSalus is Latin for ‘creating good health.’

For additional information, please contact Jim Geisler at 502 515 1100 ext 102 or jgeisler@creosalus.com. An overview of the company is also available at www.creosalus.com.